Free Trial
NYSE:BDR

Blonder Tongue Laboratories (BDR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
190,300 shs
Average Volume
364,033 shs
Market Capitalization
$4.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BDR stock logo

About Blonder Tongue Laboratories Stock (NYSE:BDR)

Blonder Tongue Laboratories, Inc. operates as a technology development and manufacturing company, which engages in delivering television signal encoding, transcoding, digital transport, and broadband product solutions for applications. It also offers system operators and integrators serving the cable, broadcast, satellite, institutional, and professional video markets with solutions for the provision of content contribution, distribution, and video delivery to homes and businesses. The company was founded by Ben H. Tongue and Isaac S. Blonder in 1950 and is headquartered in Old Bridge, NJ.

BDR Stock News Headlines

Abbott Laboratories (ABT)
See More Headlines
Receive BDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blonder Tongue Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Telecommunications Equipment
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$4.06 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Edward R. Grauch
    President & Chief Executive Officer
  • Allen Horvath
    Senior Vice President-Operations
  • Eric S. Skolnik
    CFO, Secretary, Treasurer & Senior Vice President
  • Ronald V. Alterio
    Chief Technology Officer & Senior VP-Engineering
  • Robert J. Pallé
    Director & Managing Director-Strategic Accounts

BDR Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Blonder Tongue Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Blonder Tongue Laboratories investors own include Wheeler Real Estate Investment Trust (WHLR), BurgerFi International (OPES), Karyopharm Therapeutics (KPTI) and Gold Fields (GFI).

This page (NYSE:BDR) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners